Clinical and cost-effectiveness of left ventricular assist devices as destination therapy for people with end-stage heart failure: a systematic review and economic evaluation
Clinical and cost-effectiveness of left ventricular assist devices as destination therapy for people with end-stage heart failure: a systematic review and economic evaluation
OBJECTIVES: The clinical and cost-effectiveness of left ventricular assist devices as destination therapy for people with end-stage heart failure is assessed through a systematic review and economic evaluation.
METHODS: Systematic review was performed of randomized controlled trials, quasiexperimental studies,case series, and case studies identified through searching eighteen electronic databases, bibliographies, and consultation with experts and manufacturers. Studies assessed survival, functional capacity, and quality of life. Cost effectiveness was assessed through a 5-year decision analytic model to estimate the incremental cost-effectiveness ratio for using left ventricular assist devices compared with usual care.
RESULTS: Six studies met the inclusion criteria, showing that left ventricular assist devices appear beneficial, improving survival and quality of life. Adverse events are a serious concern. The economic evaluation showed that left ventricular assist devices had a cost per quality adjusted life year of 170,616 pounds. Sensitivity analysis showed that the cost-effectiveness was not sensitive to changes in costs or utility.
CONCLUSIONS: Although left ventricular assist devices appear clinically effective as destination therapy, it is unlikely they will be cost-effective unless costs decrease or the benefits of their use increase.
heart failure, left ventricular assist devices, systematic review, economic evaluation, health technology assessment
261-268
Clegg, Andrew J.
838091f5-39df-4dbe-a369-675b26f2301b
Scott, David A.
19b5fd34-9974-4ae4-8be0-27a693639e20
Loveman, Emma
06ff1bf1-0189-4330-b22d-f5a917e9871d
Colquitt, Jill
741c69a3-d9e0-4f10-b457-e496541e7915
Royle, Pam
65edd3b7-b4cc-4563-9269-e7ebf23ef425
Bryant, Jackie
cd84de60-e9a2-4d7a-8ec6-6ca6276b12aa
April 2007
Clegg, Andrew J.
838091f5-39df-4dbe-a369-675b26f2301b
Scott, David A.
19b5fd34-9974-4ae4-8be0-27a693639e20
Loveman, Emma
06ff1bf1-0189-4330-b22d-f5a917e9871d
Colquitt, Jill
741c69a3-d9e0-4f10-b457-e496541e7915
Royle, Pam
65edd3b7-b4cc-4563-9269-e7ebf23ef425
Bryant, Jackie
cd84de60-e9a2-4d7a-8ec6-6ca6276b12aa
Clegg, Andrew J., Scott, David A., Loveman, Emma, Colquitt, Jill, Royle, Pam and Bryant, Jackie
(2007)
Clinical and cost-effectiveness of left ventricular assist devices as destination therapy for people with end-stage heart failure: a systematic review and economic evaluation.
International Journal of Technology Assessment in Health Care, 23 (2), .
(doi:10.1017/S0266462307070353).
(PMID:17493313)
Abstract
OBJECTIVES: The clinical and cost-effectiveness of left ventricular assist devices as destination therapy for people with end-stage heart failure is assessed through a systematic review and economic evaluation.
METHODS: Systematic review was performed of randomized controlled trials, quasiexperimental studies,case series, and case studies identified through searching eighteen electronic databases, bibliographies, and consultation with experts and manufacturers. Studies assessed survival, functional capacity, and quality of life. Cost effectiveness was assessed through a 5-year decision analytic model to estimate the incremental cost-effectiveness ratio for using left ventricular assist devices compared with usual care.
RESULTS: Six studies met the inclusion criteria, showing that left ventricular assist devices appear beneficial, improving survival and quality of life. Adverse events are a serious concern. The economic evaluation showed that left ventricular assist devices had a cost per quality adjusted life year of 170,616 pounds. Sensitivity analysis showed that the cost-effectiveness was not sensitive to changes in costs or utility.
CONCLUSIONS: Although left ventricular assist devices appear clinically effective as destination therapy, it is unlikely they will be cost-effective unless costs decrease or the benefits of their use increase.
This record has no associated files available for download.
More information
Published date: April 2007
Keywords:
heart failure, left ventricular assist devices, systematic review, economic evaluation, health technology assessment
Organisations:
Faculty of Medicine
Identifiers
Local EPrints ID: 345700
URI: http://eprints.soton.ac.uk/id/eprint/345700
ISSN: 0266-4623
PURE UUID: 39e3ee8b-6e3d-48b6-b9ec-9f55889732c3
Catalogue record
Date deposited: 25 Feb 2013 14:50
Last modified: 15 Mar 2024 04:07
Export record
Altmetrics
Contributors
Author:
David A. Scott
Author:
Pam Royle
Author:
Jackie Bryant
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics